We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Coherus Oncology
CHRS
$225M
| $53.4M | 0.17% |
+2,414,338
| New | +$41.9M |
|
202
Boston Properties
BXP
$11B
| $52.6M | 0.17% |
408,000
-6,500
| -2% | -$873K |
|
203
Prudential Financial
PRU
$42.3B
| $52.6M | 0.17% |
521,000
+3,700
| +0.7% | +$369K |
|
204
Boeing
BA
$167B
| $52.3M | 0.17% |
143,776
-131,791
| -48% | -$48.1M |
|
205
Fox Factory Holding Corp
FOXF
$779M
| $52.3M | 0.17% |
633,914
+90,396
| +17% | +$6.7M |
|
206
Malibu Boats
MBUU
$557M
| $51.8M | 0.17% |
1,333,787
+141,107
| +12% | +$5.6M |
|
207
Accenture
ACN
$94.3B
| $51.8M | 0.17% |
280,299
+41,105
| +17% | +$7.38M |
|
|
EXAS
208
DELISTED
Exact Sciences
EXAS
| $51.4M | 0.17% |
435,728
+14,188
| +3% | +$1.43M |
|
209
Steris
STE
$21.3B
| $51.4M | 0.17% |
345,032
+8,229
| +2% | +$1.1M |
|
210
Amgen
AMGN
$203B
| $51.1M | 0.17% |
277,490
+120,490
| +77% | +$21.6M |
|
|
UN
211
DELISTED
Unilever NV New York Registry Shares
UN
| $51M | 0.17% |
840,006
-11,871
| -1% | -$710K |
|
212
Carnival Corporation Ltd
CCL
$37.1B
| $51M | 0.17% |
1,095,400
-17,000
| -2% | -$890K |
|
213
Eastman Chemical
EMN
$7.74B
| $50.8M | 0.16% |
652,100
-276,456
| -30% | -$21M |
|
214
Thermo Fisher Scientific
TMO
$208B
| $50.5M | 0.16% |
171,856
-418
| -0.2% | -$115K |
|
215
Workday
WDAY
$36.4B
| $50.5M | 0.16% |
245,456
-45,427
| -16% | -$9.17M |
|
216
SLB Ltd
SLB
$76.5B
| $50.3M | 0.16% |
1,265,900
-19,600
| -2% | -$790K |
|
217
Alibaba
BABA
$276B
| $50.2M | 0.16% |
296,502
-84,997
| -22% | -$14.7M |
|
|
COUP
218
DELISTED
Coupa Software Incorporated
COUP
| $50.1M | 0.16% |
395,648
-116,942
| -23% | -$12.5M |
|
219
Western Alliance Bancorporation
WAL
$9.04B
| $49.8M | 0.16% |
1,114,056
-680,587
| -38% | -$30.4M |
|
|
HRC
220
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $49.8M | 0.16% |
475,652
-522,787
| -52% | -$52.9M |
|
221
iRhythm Holdings
IRTC
$3.69B
| $49.6M | 0.16% |
627,044
+29,378
| +5% | +$2.14M |
|
222
Sarepta Therapeutics
SRPT
$1.68B
| $49.2M | 0.16% |
323,553
+245
| +0.1% | +$29.8K |
|
223
AvalonBay Communities
AVB
$26.8B
| $48.9M | 0.16% |
240,800
+80,200
| +50% | +$16.3M |
|
224
F5
FFIV
$23B
| $48.5M | 0.16% |
332,869
-4,948
| -1% | -$741K |
|
225
Packaging Corp of America
PKG
$22.5B
| $48.1M | 0.16% |
505,100
-84,549
| -14% | -$8.16M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.